ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | 100.0% | – | |
| – | 236.1% | 124.5% | – | – | – | – | – | – | – | – | – | |
| – | -136.1% | -24.5% | – | – | – | – | – | – | – | 100.0% | – | |
| 3,338.7% | 6,091.2% | 2,786.1% | – | – | – | – | – | – | – | 56.3% | – | |
| – | – | – | – | – | – | – | – | – | – | 82.6% | – | |
| 6,672.4% | 10,082.5% | 4,927.5% | – | – | – | – | – | – | – | 138.8% | – | |
| -6,922.0% | -10,218.6% | -4,952.0% | – | – | – | – | – | – | – | -38.8% | – | |
| 85.6% | 3.7% | – | – | – | – | – | – | – | – | 18.0% | – | |
| -9,225.2% | -24,085.0% | -11,930.6% | – | – | – | – | – | – | – | -49.4% | – | |
| – | – | -906.7% | – | – | – | – | – | – | – | – | – | |
| -9,225.2% | -24,085.0% | -11,023.9% | – | – | – | – | – | – | – | -49.4% | – | |
| -6,572.4% | -9,982.5% | -4,827.5% | – | – | – | – | – | – | – | -28.9% | – |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.